GLASS Manual for Antimicrobial Resistance Surveillance in Common Bacteria Causing Human Infection.
Saved in:
Place / Publishing House: | Geneva : : World Health Organization,, 2023. ©2023. |
---|---|
Year of Publication: | 2023 |
Edition: | 1st ed. |
Language: | English |
Online Access: | |
Physical Description: | 1 online resource (72 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
50030733622 |
---|---|
ctrlnum |
(MiAaPQ)50030733622 (Au-PeEL)EBL30733622 (OCoLC)1396699152 |
collection |
bib_alma |
record_format |
marc |
spelling |
GLASS Manual for Antimicrobial Resistance Surveillance in Common Bacteria Causing Human Infection. 1st ed. Geneva : World Health Organization, 2023. ©2023. 1 online resource (72 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Intro -- Acknowledgements -- Abbreviations and acronyms -- Introduction -- 1.1 Background -- 1.2 GLASS early implementation and revision -- 1.3 Scope and purpose of the manual -- 1.4 What is new in GLASS methods for AMR surveillance? -- 2 Objectives of GLASS AMR surveillance -- 3 Core components of a national AMR surveillance system -- 3.1 National coordinating centre -- 3.2 National reference laboratory -- 3.3 Surveillance sites -- 4 AMR surveillance principles -- 5 GLASS approaches for AMR surveillance -- 5.1 Population under surveillance -- 5.2 Data collection -- 5.3 Considerations when generating AMR estimates for the target population using data collected through the surveillance system -- 5.4 Assumptions and limitations of GLASS-AMR surveillance based on routine clinical patient sampling -- 6 Approaches to improve data quality and representativeness -- 6.1 Enhancing the quality of surveillance based on routine diagnostic testing -- 6.2 Assessment of an AMR surveillance system based on routine diagnostic testing -- 6.3 National AMR prevalence surveys to improve the quality and representativeness of national AMR surveillance data (GLASS-AMR surveys) -- 7 GLASS-AMR surveillance targets -- 7.1 Specimen types and target pathogens -- 7.2 Antimicrobial-pathogen combinations -- 7.3 Molecular targets -- 8 Annual AMR data submission to GLASS -- 8.1 Aggregated data -- 8.2 Individual-level data -- 8.3 Collection of data on the status of national surveillance system -- 9 Collection, management, analysis and reporting of data -- 9.1 GLASS data flow -- 9.2 Collection and management of data at surveillance sites -- 9.3 Laboratory procedures at surveillance sites -- 9.4 Collection and management of data at the national level -- 9.5 Checking quality of data at the local level -- 10 Analysis and reporting of data -- 10.1 Key AMR metrics for global reporting. References -- Annex 1 RIS dataset variables -- Annex 2. SAMPLE dataset variables -- Annex 3. Coded values for variables collected with national aggregated data -- Annex 4. Coded values for variables collected with individual data -- Annex 5. Types of care -- Annex 6. Implementation questionnaire -- Annex 7. Molecular indicators. Description based on publisher supplied metadata and other sources. Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. Electronic books. Print version: GLASS Manual for Antimicrobial Resistance Surveillance in Common Bacteria Causing Human Infection Geneva : World Health Organization,c2023 ProQuest (Firm) https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=30733622 Click to View |
language |
English |
format |
eBook |
title |
GLASS Manual for Antimicrobial Resistance Surveillance in Common Bacteria Causing Human Infection. |
spellingShingle |
GLASS Manual for Antimicrobial Resistance Surveillance in Common Bacteria Causing Human Infection. Intro -- Acknowledgements -- Abbreviations and acronyms -- Introduction -- 1.1 Background -- 1.2 GLASS early implementation and revision -- 1.3 Scope and purpose of the manual -- 1.4 What is new in GLASS methods for AMR surveillance? -- 2 Objectives of GLASS AMR surveillance -- 3 Core components of a national AMR surveillance system -- 3.1 National coordinating centre -- 3.2 National reference laboratory -- 3.3 Surveillance sites -- 4 AMR surveillance principles -- 5 GLASS approaches for AMR surveillance -- 5.1 Population under surveillance -- 5.2 Data collection -- 5.3 Considerations when generating AMR estimates for the target population using data collected through the surveillance system -- 5.4 Assumptions and limitations of GLASS-AMR surveillance based on routine clinical patient sampling -- 6 Approaches to improve data quality and representativeness -- 6.1 Enhancing the quality of surveillance based on routine diagnostic testing -- 6.2 Assessment of an AMR surveillance system based on routine diagnostic testing -- 6.3 National AMR prevalence surveys to improve the quality and representativeness of national AMR surveillance data (GLASS-AMR surveys) -- 7 GLASS-AMR surveillance targets -- 7.1 Specimen types and target pathogens -- 7.2 Antimicrobial-pathogen combinations -- 7.3 Molecular targets -- 8 Annual AMR data submission to GLASS -- 8.1 Aggregated data -- 8.2 Individual-level data -- 8.3 Collection of data on the status of national surveillance system -- 9 Collection, management, analysis and reporting of data -- 9.1 GLASS data flow -- 9.2 Collection and management of data at surveillance sites -- 9.3 Laboratory procedures at surveillance sites -- 9.4 Collection and management of data at the national level -- 9.5 Checking quality of data at the local level -- 10 Analysis and reporting of data -- 10.1 Key AMR metrics for global reporting. References -- Annex 1 RIS dataset variables -- Annex 2. SAMPLE dataset variables -- Annex 3. Coded values for variables collected with national aggregated data -- Annex 4. Coded values for variables collected with individual data -- Annex 5. Types of care -- Annex 6. Implementation questionnaire -- Annex 7. Molecular indicators. |
title_full |
GLASS Manual for Antimicrobial Resistance Surveillance in Common Bacteria Causing Human Infection. |
title_fullStr |
GLASS Manual for Antimicrobial Resistance Surveillance in Common Bacteria Causing Human Infection. |
title_full_unstemmed |
GLASS Manual for Antimicrobial Resistance Surveillance in Common Bacteria Causing Human Infection. |
title_auth |
GLASS Manual for Antimicrobial Resistance Surveillance in Common Bacteria Causing Human Infection. |
title_new |
GLASS Manual for Antimicrobial Resistance Surveillance in Common Bacteria Causing Human Infection. |
title_sort |
glass manual for antimicrobial resistance surveillance in common bacteria causing human infection. |
publisher |
World Health Organization, |
publishDate |
2023 |
physical |
1 online resource (72 pages) |
edition |
1st ed. |
contents |
Intro -- Acknowledgements -- Abbreviations and acronyms -- Introduction -- 1.1 Background -- 1.2 GLASS early implementation and revision -- 1.3 Scope and purpose of the manual -- 1.4 What is new in GLASS methods for AMR surveillance? -- 2 Objectives of GLASS AMR surveillance -- 3 Core components of a national AMR surveillance system -- 3.1 National coordinating centre -- 3.2 National reference laboratory -- 3.3 Surveillance sites -- 4 AMR surveillance principles -- 5 GLASS approaches for AMR surveillance -- 5.1 Population under surveillance -- 5.2 Data collection -- 5.3 Considerations when generating AMR estimates for the target population using data collected through the surveillance system -- 5.4 Assumptions and limitations of GLASS-AMR surveillance based on routine clinical patient sampling -- 6 Approaches to improve data quality and representativeness -- 6.1 Enhancing the quality of surveillance based on routine diagnostic testing -- 6.2 Assessment of an AMR surveillance system based on routine diagnostic testing -- 6.3 National AMR prevalence surveys to improve the quality and representativeness of national AMR surveillance data (GLASS-AMR surveys) -- 7 GLASS-AMR surveillance targets -- 7.1 Specimen types and target pathogens -- 7.2 Antimicrobial-pathogen combinations -- 7.3 Molecular targets -- 8 Annual AMR data submission to GLASS -- 8.1 Aggregated data -- 8.2 Individual-level data -- 8.3 Collection of data on the status of national surveillance system -- 9 Collection, management, analysis and reporting of data -- 9.1 GLASS data flow -- 9.2 Collection and management of data at surveillance sites -- 9.3 Laboratory procedures at surveillance sites -- 9.4 Collection and management of data at the national level -- 9.5 Checking quality of data at the local level -- 10 Analysis and reporting of data -- 10.1 Key AMR metrics for global reporting. References -- Annex 1 RIS dataset variables -- Annex 2. SAMPLE dataset variables -- Annex 3. Coded values for variables collected with national aggregated data -- Annex 4. Coded values for variables collected with individual data -- Annex 5. Types of care -- Annex 6. Implementation questionnaire -- Annex 7. Molecular indicators. |
isbn |
9789240076600 |
genre |
Electronic books. |
genre_facet |
Electronic books. |
url |
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=30733622 |
illustrated |
Not Illustrated |
oclc_num |
1396699152 |
status_str |
n |
ids_txt_mv |
(MiAaPQ)50030733622 (Au-PeEL)EBL30733622 (OCoLC)1396699152 |
carrierType_str_mv |
cr |
is_hierarchy_title |
GLASS Manual for Antimicrobial Resistance Surveillance in Common Bacteria Causing Human Infection. |
marc_error |
Minor Error : Subfield of zero length encountered, ignoring it. --- [ 776 : i ] Info : MARC8 translation shorter than ISO-8859-1, choosing MARC8. --- [ 856 : z ] |
_version_ |
1792331072833323008 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03684nam a22003493i 4500</leader><controlfield tag="001">50030733622</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20240229073851.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cnu||||||||</controlfield><controlfield tag="008">240229s2023 xx o ||||0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789240076600</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)50030733622</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL30733622</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1396699152</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">GLASS Manual for Antimicrobial Resistance Surveillance in Common Bacteria Causing Human Infection.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Geneva :</subfield><subfield code="b">World Health Organization,</subfield><subfield code="c">2023.</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2023.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (72 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Intro -- Acknowledgements -- Abbreviations and acronyms -- Introduction -- 1.1 Background -- 1.2 GLASS early implementation and revision -- 1.3 Scope and purpose of the manual -- 1.4 What is new in GLASS methods for AMR surveillance? -- 2 Objectives of GLASS AMR surveillance -- 3 Core components of a national AMR surveillance system -- 3.1 National coordinating centre -- 3.2 National reference laboratory -- 3.3 Surveillance sites -- 4 AMR surveillance principles -- 5 GLASS approaches for AMR surveillance -- 5.1 Population under surveillance -- 5.2 Data collection -- 5.3 Considerations when generating AMR estimates for the target population using data collected through the surveillance system -- 5.4 Assumptions and limitations of GLASS-AMR surveillance based on routine clinical patient sampling -- 6 Approaches to improve data quality and representativeness -- 6.1 Enhancing the quality of surveillance based on routine diagnostic testing -- 6.2 Assessment of an AMR surveillance system based on routine diagnostic testing -- 6.3 National AMR prevalence surveys to improve the quality and representativeness of national AMR surveillance data (GLASS-AMR surveys) -- 7 GLASS-AMR surveillance targets -- 7.1 Specimen types and target pathogens -- 7.2 Antimicrobial-pathogen combinations -- 7.3 Molecular targets -- 8 Annual AMR data submission to GLASS -- 8.1 Aggregated data -- 8.2 Individual-level data -- 8.3 Collection of data on the status of national surveillance system -- 9 Collection, management, analysis and reporting of data -- 9.1 GLASS data flow -- 9.2 Collection and management of data at surveillance sites -- 9.3 Laboratory procedures at surveillance sites -- 9.4 Collection and management of data at the national level -- 9.5 Checking quality of data at the local level -- 10 Analysis and reporting of data -- 10.1 Key AMR metrics for global reporting.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">References -- Annex 1 RIS dataset variables -- Annex 2. SAMPLE dataset variables -- Annex 3. Coded values for variables collected with national aggregated data -- Annex 4. Coded values for variables collected with individual data -- Annex 5. Types of care -- Annex 6. Implementation questionnaire -- Annex 7. Molecular indicators.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="590" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. </subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">GLASS Manual for Antimicrobial Resistance Surveillance in Common Bacteria Causing Human Infection</subfield><subfield code="d">Geneva : World Health Organization,c2023</subfield></datafield><datafield tag="797" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=30733622</subfield><subfield code="z">Click to View</subfield></datafield></record></collection> |